These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10395031)

  • 1. NGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells.
    Gazi L; Sommer B; Nozulak J; Schoeffter P
    Eur J Pharmacol; 1999 May; 372(3):R9-10. PubMed ID: 10395031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NGD 94-1: a specific dopamine-4-receptor antagonist.
    Tallman JF
    Adv Pharmacol; 1998; 42():490-2. PubMed ID: 9327946
    [No Abstract]   [Full Text] [Related]  

  • 5. Modulation of the clozapine structure increases its selectivity for the dopamine D4 receptor.
    Liégeois JF; Bruhwyler J; Damas J; Rogister F; Masereel B; Geczy J; Delarge J
    Eur J Pharmacol; 1995 Feb; 273(3):R1-3. PubMed ID: 7737323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
    Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel iodinated ligand, IPMPP, for human dopamine D4 receptors expressed in CHO cells.
    Kung MP; Stevenson DA; Zhuang ZP; Vessotskie JM; Chumpradit S; Sun XM; Kung HF
    Life Sci; 1997; 60(2):91-100. PubMed ID: 9000114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors.
    Watts VJ; Vu MN; Wiens BL; Jovanovic V; Van Tol HH; Neve KA
    Psychopharmacology (Berl); 1999 Jan; 141(1):83-92. PubMed ID: 9952069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional coupling of human D2, D3, and D4 dopamine receptors in HEK293 cells.
    McAllister G; Knowles MR; Ward-Booth SM; Sinclair HA; Patel S; Marwood R; Emms F; Patel S; Smith A; Seabrook GR
    J Recept Signal Transduct Res; 1995; 15(1-4):267-81. PubMed ID: 8903944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of S(+)N-n-propylnorapomorphine compared with typical and atypical antipsychotics: differential increases of cerebrocortical D2-like and striatolimbic D4-like dopamine receptors.
    Tarazi FI; Yeghiayan SK; Baldessarini RJ; Kula NS; Neumeyer JL
    Neuropsychopharmacology; 1997 Sep; 17(3):186-96. PubMed ID: 9272485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors.
    Seeman P; Corbett R; Van Tol HH
    Neuropsychopharmacology; 1997 Feb; 16(2):93-110; discussion 111-35. PubMed ID: 9015795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 study.
    Lahti RA; Roberts RC; Cochrane EV; Primus RJ; Gallager DW; Conley RR; Tamminga CA
    Mol Psychiatry; 1998 Nov; 3(6):528-33. PubMed ID: 9857979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.
    Thurkauf A; Yuan J; Chen X; He XS; Wasley JW; Hutchison A; Woodruff KH; Meade R; Hoffman DC; Donovan H; Jones-Hertzog DK
    J Med Chem; 1997 Jan; 40(1):1-3. PubMed ID: 9016321
    [No Abstract]   [Full Text] [Related]  

  • 15. Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2/D3 partial agonist.
    Burstein ES; Ma J; Wong S; Gao Y; Pham E; Knapp AE; Nash NR; Olsson R; Davis RE; Hacksell U; Weiner DM; Brann MR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1278-87. PubMed ID: 16135699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-168077, a selective dopamine D4 receptor agonist, induces penile erection when injected into the paraventricular nucleus of male rats.
    Melis MR; Succu S; Mascia MS; Argiolas A
    Neurosci Lett; 2005 Apr; 379(1):59-62. PubMed ID: 15814200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to finding specific dopamine D4 receptor agonists.
    Morishita H; Shibata K; Sakata N; Kita S; Katsuragi T
    Eur J Pharmacol; 2005 Jun; 516(2):145-50. PubMed ID: 15922324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacology of a human dopamine D4 receptor expressed in HEK293 cells.
    Lawson CF; Mortimore RA; Schlachter SK; Smith MW
    Methods Find Exp Clin Pharmacol; 1994 Jun; 16(5):303-7. PubMed ID: 7934308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D4 dopamine receptor-mediated phospholipid methylation and its implications for mental illnesses such as schizophrenia.
    Sharma A; Kramer ML; Wick PF; Liu D; Chari S; Shim S; Tan W; Ouellette D; Nagata M; DuRand CJ; Kotb M; Deth RC
    Mol Psychiatry; 1999 May; 4(3):235-46. PubMed ID: 10395213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.